Hippo-YAP1 dysregulation as a central driver of therapeutic resistance in cancer: Mechanisms and targeting therapeutic strategies.
- DOI
- 10.1016/j.critrevonc.2026.105557
- Published
- 2026 Aug 22
- Container
- Critical reviews in oncology/hematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.critrevonc.2026.105557,
title = {Hippo-YAP1 dysregulation as a central driver of therapeutic resistance in cancer: Mechanisms and targeting therapeutic strategies.},
author = {Zhao J and Zheng W and Zhang Y and He J and Shan H and Wang B and Guo L and Liang T},
year = {2026},
journal = {Critical reviews in oncology/hematology},
doi = {10.1016/j.critrevonc.2026.105557},
url = {https://doi.org/10.1016/j.critrevonc.2026.105557}
}RIS
TY - JOUR TI - Hippo-YAP1 dysregulation as a central driver of therapeutic resistance in cancer: Mechanisms and targeting therapeutic strategies. AU - Zhao J AU - Zheng W AU - Zhang Y AU - He J AU - Shan H AU - Wang B AU - Guo L AU - Liang T PY - 2026 JO - Critical reviews in oncology/hematology DO - 10.1016/j.critrevonc.2026.105557 UR - https://doi.org/10.1016/j.critrevonc.2026.105557 ER -
APA
J, Z., W, Z., Y, Z., J, H., H, S., B, W., L, G., & T, L. (2026). Hippo-YAP1 dysregulation as a central driver of therapeutic resistance in cancer: Mechanisms and targeting therapeutic strategies.. Critical reviews in oncology/hematology. https://doi.org/10.1016/j.critrevonc.2026.105557
Source records
- pubmed · retrieved 2026-09-27T00:37:41.549Z